LeapZipBlog: Steve Blade

Steve Blade's blog

1236 blogs

Global Atherosclerotic Renovascular Treatment Market Expected to Deliver Greater Revenue Share Motivated by Vast Product Preference during 2018-2028

April 19, 2019 by Steve Blade  

A fresh study, covering “Global Atherosclerotic Renovascular Treatment Market Insights, Trends & Future Development Status Recorded during 2018-2028” has been broadcasted to wide online repository of FactMR, which presents deep focus on the Atherosclerotic Renovascular Treatment Market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make the research a powerful source for analysts and industry experts who are looking to gain necessary knowledge about the prevailing market trends, opportunities and drivers present in the “Atherosclerotic Renovascular Treatment Market”. 

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=2035

Atherosclerotic renovascular disease refers to the stenosis of either one or both renal arteries. The stenosis occurs due to the accumulation of fat or calcium deposits on the walls of the artery. Atherosclerotic renovascular disease is a rare disorder and its exact epidemiology is not available. Although the prevalence of atherosclerotic renovascular disease is not known, the dialysis registry data provides some hint of patients with atherosclerotic renovascular disease. In a study conducted on cardiovascular health in the U.S. about 6.8% of healthy candidates over the age of 65 years are found to have clinically silent atherosclerotic renovascular disease. Atherosclerotic renovascular disease is increasingly gaining recognition and importance. This is due to the condition of patients as they tend to go for dialysis, which reflects their systemic atherosclerotic burden. In an effort to delay and perhaps prevent their need for renal replacement therapy, some patients are subjected to a variety of medical, radiological and surgical interventions. The management of atherosclerotic renovascular disease is controversial. Some evidence suggests that treatment with renal stent may be beneficial, however, clinical trials have failed to demonstrate significant benefits.

Over the past 80 years there has been a significant change in the understanding of atherosclerotic renovascular treatment. Currently, the atherosclerotic renovascular treatment consists of medical therapy, angioplasty, renal artery stenting and surgery. Patients who show mild to medium symptoms can benefit with the use of atherosclerotic renovascular treatment by medical therapy. This mode of atherosclerotic renovascular treatment generally includes the use of drugs particularly anti-hypertension drugs, exercise and regular check-ups. Angioplasty for atherosclerotic renovascular treatment is also beneficial in case of patients who have significant narrowing of the renal artery. However, in case the angioplasty atherosclerotic renovascular treatment is not sufficient or if it is an ineffective atherosclerotic renovascular treatment, renal artery stenting can be performed to ensure the dilated artery maintains its structure.

To know more about the Atherosclerotic Renovascular Treatment Market Visit the link- https://www.factmr.com/report/2035/atherosclerotic-renovascular-treatment-market

Atherosclerotic renovascular treatment by surgery is recommended to patients with severely high blood pressure or renal failure. The surgical atherosclerotic renovascular treatment is of two types. The first type is a renal artery endarterectomy, the plaque in the renal artery is removed through an incision through the abdomen. Another form of atherosclerotic renovascular treatment by surgery is that of renal artery bypass. In this type of surgery the defected or plaque section of the renal artery is removed and replaced with a healthy vein from another part of the body. Patients undergoing atherosclerotic renovascular treatment by surgery need to be in the hospital for about a week.

Atherosclerotic Renovascular Treatment Market: Drivers and Restraints

Increase in ageing population and with the increase in prevalence of various conditions such as cardiovascular conditions, diabetes, smoking and hypertension drive the growth of the atherosclerotic renovascular treatment market. However, other factors such as high rate of unsuccessful renal revascularization as an atherosclerotic renovascular treatment may hinder the growth of the atherosclerotic renovascular treatment market.

Atherosclerotic Renovascular Treatment Market: Overview

The global atherosclerotic renovascular treatment is expected to witness moderate growth over the forecast period. The atherosclerotic renovascular treatments can be broadly classified based on the treatment as medical treatment, angioplasty, renal artery stenting and surgery. The atherosclerotic renovascular treatment by renal revascularization methods such as angioplasty and renal artery stenting have tough competition from players that offer hypertension drug products used for atherosclerotic renovascular treatments.

Atherosclerotic Renovascular Treatment Market: Regional Outlook

Geographically, the global atherosclerotic renovascular treatment market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global atherosclerotic renovascular treatment market owing to technology advancements, awareness of general public, increasing healthcare spending and substantial reimbursement. The atherosclerotic renovascular treatment market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to increased R&D spending and advancements in technology.

Atherosclerotic Renovascular Treatment Market: Key Players

The global market for atherosclerotic renovascular treatment is highly fragmented. Examples of some of the key players operating in the global atherosclerotic renovascular treatment market are Boston Scientific, Abbott, Cook Medical, Medtronic PLC, and Cordis Corporation, among others.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=2035

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://theswisstimes.com

 

 

 

Global Antibacterial Washcloth Market Innovative Trends Implemented by Manufacturers Steering Growth until 2028

April 19, 2019 by Steve Blade  

A precise investigation of the “Antibacterial Washcloth Market” market will be soon published to the vast online repository managed by FactMR The purpose of this report would be to present clear insights about the different market features such as revenue share, market size, market dynamics, competitive scenario and a lot more. Furthermore, readers would be provided section wise detailing concerning product catalogue, applications and end-user contributions during the stated forecast period.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=2190

Antibacterial washcloths are generally under use for many different applications which require antiseptic and clean approach towards the use. The antibacterial washcloth is far more used in critical areas such as hospital, where the antibacterial washcloth is restricted to be used for deep or punctured wounds, animal bites and serious burns. They help in potentially reducing the intensity of germs, which can potentially cause infection to the patient. Antibacterial washcloths have a clinical advantage over other wipes alternative as the washcloth remain an option that can be used at room temperature or could be heated in microwave. Antibacterial washcloths provide a gentle texture against the users face to create a smoother and with often use of antibacterial washcloth it does not allow the bacteria to spread or communicate through towels in case. Methods such as forming antibacterial cloth with bamboo is subject to of high interest with antibacterial washcloths, due to bamboo’s renewable quality and abundant amount of raw material that can be supported during its manufacturing which states to be the biggest quality difference.

Antibacterial Washcloth Market: Drivers and Restraints

Antibacterial washcloth is used in processes where the patient is provided with a series of such antibacterial washcloths to clean the body. Though washcloths are subjected to be a bad reason the beauty industry due to its bacterial disinfection quality but is more of a major part in the after process cleanliness. The industry is coming up with recent technologies which will providing a far different set of antibacterial washcloths, washcloths made up of linen and bamboo are few of the recent major trends being followed for better resultant products. As antibacterial washcloths are consumable products which are meant to be sold and manufactured in bulk.

To know more about the Antibacterial Washcloth Market Visit the link- https://www.factmr.com/report/2190/antibacterial-washcloth-market

The recent processes are performed with complete manufacturing of antibacterial washcloths with cloth material which are antiseptic and the raw material used is procured form field outsources. The market for antibacterial washcloths would rise with increase in number of people consuming such method for general applications. And with increase in market capability it provides the antibacterial washcloth requirement more prominent with procedures with opportunities providing a more meaningful importance in their use. Technology that has led the market to adopt new methods in order to form better pattern and material choice would now also new approaches for better initial response in healthcare sectors at the consumer end.

Antibacterial Washcloth Market: Overview

The global market for antibacterial washcloth is expected to introduce new product lines over a period due to majority of antibacterial washcloths are meant for consumers with home care use. The growth is related to the rising number of health cases that uses antibacterial washcloth, which is mostly observed in people in high income economy. As antibacterial washcloth is a consumable market for an effective cleaning technique used for patients in hospitals and well used in general homecare.  Among the material types, the bamboo based antibacterial washcloth is expected to be a prominent technology and choice of material for the production. In the end user segment the homecare settings provides a deeper score for manufacturer to penetrate the markets with advertising and consumer awareness regarding antibacterial washcloth.

Antibacterial Washcloth Market: Regional Outlook

Geographically, the global antibacterial washcloth market is segmented into North America, Latin America, Europe, CIS & Russia, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global antibacterial washcloth market owing to high prevalence of the reported cases and healthcare infrastructure and with consumer solid awareness regarding such product. The antibacterial washcloth market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to expansion of offerings by the key providers. Europe is expected to have a large share in the global antibacterial washcloth market throughout the forecast period due to its quality healthcare facilities and modern outlook for antibacterial washcloth use.

Antibacterial Washcloth Market: Key Players

The global market for antibacterial washcloth market is highly fragmented. Examples of some of the key players operating in the global Antibacterial washcloth market are Berk International, Graham Medical, TIDI Products LLC, Stryker, Clinicept Healthcare Ltd, Reynard Health Supplies, Reynard Health Supplies, Sage Products LLC, and GAMA HEALTHCARE LTD. 

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=2190

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - http://theguardiantribune.com

 

Allergic Rhinitis Treatment Device Market Inclinations Highlighting Enhanced Revenue in the Coming Years

April 19, 2019 by Steve Blade  

The allergic rhinitis treatment devices are employed for treatment of allergic rhinitis. They help in preventing further exposure to allergens and relieving the symptoms such as runny nose. The allergic rhinitis treatment devices use a variety of mechanisms such as irradiations by lasers or filters to block exposure to allergens. The Allergic Rhinitis Treatment Device Market are intended to full fill the unmet needs of the market owing to poor efficacy and efficiency of the drug segment. Development in technology and the advancements in photo therapy coupled with the growing demand from home users is expected to propel the market to a high growth trajectory.

Request TOC of this Report-https://www.factmr.com/connectus/sample?flag=T&rep_id=2272

Allergic Rhinitis Treatment Device Market: Drivers and Restraints

The rising incidence and cases of allergic rhinitis is the prime driver of the allergic rhinitis treatment devices market. According to the American Academy of Allergy, Asthma & Immunology, 7.8% of people over 18 years of age in the U.S. suffer from allergic rhinitis. The data also reveals that allergic rhinitis affects between 10% and 30 % of the global population and sensitization is present in 40% of the population. The large economic burden of allergic rhinitis is another driver of the market as allergies is the 6th leading cause of chronic illness in the U.S. resulting in an annual penalty exceeding a whopping US$ 18 billion. The Asthma and Allergy Foundation of America states that 50 million U.S. citizens suffer from allergies each year.

Advancement in technology is another driver of the allergic rhinitis treatment device market. The advent of cryotherapy which uses cold temperatures to interrupts the errant nerve signals and treat inflamed nerves in chronic rhinitis is driving the growth of the market. The cryotherapy allergic rhinitis treatment devices include a miniature chilled pad fixed to a thin stem and applied to a mucus membrane inside the nasal cavity. Another advancement has been the application of radio therapy for treating allergic rhinitis. Photodynamic therapy involves irradiation of the nasal cavity with a variety of irradiations such as laser, infrared rays and radio waves. Another strategy has been to physically block the exposure of allergens to the patients. Nasal filters prevent airborne allergens from reaching the mucous membranes of the nose, and are designed to fit just inside the nostril.

The rise in risk factors such as growing sports culture, growing exposure to allergens owing to pollution, increase in active populations such as young children, and others. The constraints on the allergic rhinitis treatment device market are lack of awareness, concerns over the efficacy and efficiency of the devices.

Allergic Rhinitis Treatment Device Market: Overview

The global allergic rhinitis treatment device market for is a fragmented market having a low technological intensity and a lower volume of sale resulting in low pricing premium. Vendors are engaged in new product developments as a growth strategy. The market is beset with low quality products with dubious claims and low differentiation. Technology gains from product development represent the largest value proposition over cost.

Lack of reimbursement and guidelines for use owing to the nascent stage of the technology are hindering the acceptance and market uptake of the allergic rhinitis treatment devices.

To know more about the Allergic Rhinitis Treatment Device Market Visit the link- https://www.factmr.com/report/2272/allergic-rhinitis-treatment-device-market

The global allergic rhinitis treatment device market is classified into North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan and Middle East & Africa. North America dominated by the U.S. accounts for the large share of the global allergic rhinitis treatment device market owing to the fast uptake of technology, high per capita income and the higher treatment rates for allergic rhinitis.

North America is followed by Europe which is expected to be led by Germany, France and the U.K. The large healthcare expenditure of Europe is a significant driver of the European allergic rhinitis treatment device market.

The allergic rhinitis treatment device market is expected to shift in favour of Asia Pacific and Middle East and Africa. China and India are expected to hold large shares owing to developing economy, large population base and growing medical devices penetration.

The Middle East and Africa allergic rhinitis treatment device market is expected to be dominated by the wealthy gulf economies of Saudi Arabia, Kuwait, UAE and Qatar. However, the poor income of African economies coupled with poor social conditions are hampering the allergic rhinitis treatment device market.

The global allergic rhinitis treatment device market in report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=2272

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://theswisstimes.com

 

 

Global Actigraphy Sensors Market Portrays High-End Demand across Major Geographies during 2018-2028

April 19, 2019 by Steve Blade  

Actigraphy sensors are the devices used to evaluate physical movements of an individual with sleep disorders. Actigraphy sensors collect information by monitoring body movements during sleep. Actigraphy sensors is the small portable device that collects resulting information by tracking physical motion. Actigraphy sensor is a device which is commonly worn on the wrist, ankle, or neck of the body. The device has been developed based on the assumption that when an individual sleeps, his/her body activity reduces and that activity can be used as an indicator for identifying sleep disorders. Many research studies have been going on to identify the reason for sleep disorders by evaluating the idle activity cycles of a patient. Actigraphy sensors provides more accurate data than self-reported sleep durations. Actigraphy sensors are becoming very popular among patients with sleep disorders. Manufacturers introducing novel actigraphy sensors in the market such as actigraphy watch which has accelerometer sensor that tracks real-life activities done at home. Data collected with actigraphy watch recognize wake-sleep cycles of patients which can be seen in the computer one or two week later after analysis. The data collected can help the doctor to treat the patients and detect the actual reason for the disorders. This advantage of actigraphy sensors can attribute to the growth of the Global Actigraphy Sensors Market.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=2274

According to the National Center for Biotechnology Information and U.S. National Library of Medicine, in general population, diagnosis of insomnia is only about 6%-15%. Approximately 2-4% of the population suffers from the sleep apnea syndrome. The restless legs syndrome is seen in approximately 6% of the population, with a high prevalence in geriatric population. Narcolepsy has a prevalence of 0.04% and nocturnal terrors, a prevalence of 2.2%-5%. However, most sleep disorders remain unidentified. Less than 20% of individuals are properly diagnosed and treated for sleep disorders. Extensive studies are carried out on sleep paralysis which affects approximately 6% of the general population. Among all these, parasomnias are studied less, as its prevalence remains unknown. The International Classification of Sleep Disorders listed more than 80 different types of sleep disorder diagnoses. The growing prevalence of sleep disorders are the key factors for new innovations and development of the actigraphy sensors market. However, less awareness about different types of sleep disorders and negligence of symptoms can affect the growth of the actigraphy sensors market.

To know more about the Actigraphy Sensors Market Visit the link- https://www.factmr.com/report/2274/actigraphy-sensors-market

Actigraphy Sensors Market: Drivers and Restraints

The growing prevalence of sleep disorders is the major driving factor in the growth of the actigraphy sensors market over the forecast period. The prevalence of sleep disorders was significantly higher in different shift working population which mostly remain undiagnosed. Innovations and adaptation of new technology are the other important factors contributing to the growth of the global actigraphy sensors market. However, limited awareness about different types of sleep disorders, poor lifestyle, and negligence of early symptoms is restraining the revenue growth in the global actigraphy sensors market.

Actigraphy Sensors Market: Overview

The global market for actigraphy sensors is expected to witness high growth over the forecast period. Increasing prevalence of sleeping disorders is observed in working population with unusual timings. Innovations and adaptation of new technology are the other important factors contributing to the growth of the global actigraphy sensors market.

Actigraphy Sensors Market: Regional Outlook

Geographically, the actigraphy sensors market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan, and the Middle East & Africa (MEA). North America’s actigraphy sensors market is expected to dominate the global market followed by Europe, due to significant improvement in health awareness, assessment, and expenditure along with rapidly growing economy. However, the Asia Pacific actigraphy sensors market is also estimated to grow at a high rate over the forecast period due to expansion of healthcare structure and increase in number of patient population.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=2274

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://theswisstimes.com

 

 

Global Acromegaly Treatment Market Outlook Highlights Major Opportunities Likely to Steer Demand during Forecast Period 2018 and 2028

April 19, 2019 by Steve Blade  

This research assessment managed by FactMR works to highlight the expected transformations that will occur in the “Acromegaly Treatment Market” market in the coming years. FactMR has worked diligently to compile primary market facets through this report titled “Global Acromegaly Treatment Market Inclinations & Development Status Highlighted for the Forecast Period between 2018 and 2028” which will soon be published for benefitting the readers. The availability of crucial statistics such as market revenue, market size, Y-o-Y growth, regional market share etc., will be included in the assessment for gaining better insight about the “Acromegaly Treatment Market” market during the forecast period.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=2191

Acromegaly is a hormonal disorder that is caused by the presence of excessive levels of the Growth Hormone (GH) in the body. The symptoms of acromegaly are enlargement of the bones of hands, forehead, jaws, feet and nose, which results in joint pain, thicker skin, headaches and vision problems. Complications in severe acromegaly may include type 2 diabetes, sleep apnea and elevated blood pressure. Acromegaly is generally caused when the pituitary gland produces greater levels of GI than the body normally requires, which is mostly caused by benign tumour or pituitary adenoma. The incidence of acromegaly is about 6 per 100,000 people.

Acromegaly Treatment Market: Drivers and Restraints

The rising awareness about acromegaly and an increase in the rates of screening are among the prime driver of the acromegaly treatment market. Moreover, advancements in surgery and growing alternatives, such as radiation therapy, medications and others, is driving the acromegaly treatment market. Complimentary developments in medical diagnosis, such as magnetic resonance imaging and the IGF1 & GH suppression test, provide the most sensitive and selective means for the testing of acromegaly. Advancements in medications, which include the development of antagonists, such as somatostatin analogues, dopamine agonists and GH receptor antagonists, which are the synthetic forms of natural hormones that restrict the production of GH, is driving the Acromegaly Treatment market towards non-invasive treatments, especially in cases where surgery is not feasible.

The high success rate of treatment is driving the adoption of acromegaly treatment, and life expectancy after the successful treatment of acromegaly is equal to normal.

However, high cost of surgery, which ranges from USD 3000 to USD 9,000, and difficulty in prognosis that has to be done on an individual basis are among factors expected to restrain the growth of the Acromegaly Treatment market. Moreover, complications associated with the treatment, such as the risk of infection, pain and impaired immunity, are likely to restrain the growth of the acromegaly treatment market.

To know more about the Acromegaly Treatment Market Visit the link- https://www.factmr.com/report/2191/acromegaly-treatment-market

Acromegaly Treatment Market: Overview

The global acromegaly treatment market is fragmented resulting in high pressure on pricing with numerous players dotting the scene. Vendors are engaged in new product developments, especially biologics. However, improvements in distribution efficiency is the need of the hour as strategic partnerships between market players and hospitals is expected to accelerate the uptake of acromegaly treatment. Technology gains from product development represent the largest value proposition over cost. Biologics research and the buying out of late-stage developmental drugs, which was done by Roche and Novartis, is encouraging research & development initiatives for the discovery of new drug pipelines for acromegaly treatment. 

Acromegaly Treatment Market: Regional Outlook

The global acromegaly treatment market is classified into North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan and Middle East & Africa. North America dominated by the U.S. accounts for the largest share of the global acromegaly treatment market owing to high awareness and the availability of reimbursement. According to American Society of Clinical Oncology (ASCO), about 13,210 pituitary gland tumours are expected to be diagnosed in the U.S. in 2018. According to American Brain Tumor Association, adenomas represents about 20% of the pituitary tumours. Thus, a large acromegaly treatment market with the lowest potential patient base of 20% of 13,210 people, which represents 2642 patients, is available in the US.

North America is followed by Europe, which is expected to be led by Germany, France and the U.K. The large healthcare infrastructure of Europe, which represents approximately 10% of the GDP, is a significant driver of the European acromegaly treatment market.

The acromegaly treatment market is expected to shift in favour of Asia Pacific and Middle East & Africa regions. The market in China and India is expected to grow significantly owing to developing economies, large population and advancements in healthcare.

The Middle East and Africa Acromegaly treatment market is expected to be dominated by the wealthy gulf economies of Saudi Arabia, Kuwait, UAE and Qatar. However, the poor income of African economies, coupled with poor social conditions, is hampering the acromegaly treatment market in Africa.

Acromegaly Treatment Market: Key Players

Some of the major vendors operating in the global acromegaly treatment market are Pfizer Inc., Roche Holding AG, Novartis International AG, DexTech Medical AB, Sun Pharmaceuticals Industries Ltd. and Chiasma, Inc.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=2191

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - http://theguardiantribune.com

 

 

Neonatal Monitoring Equipment: Requirement for Monitoring Complications in Premature Neonates Continues to Drive Sales

April 19, 2019 by Steve Blade  

  Relentless health monitoring for neonates has been offering essential parameters such as heart rhythm disturbances, cessation of breathing and drop in blood oxygen saturation. Neonatal monitoring system is regarded as a potent health care system with the incorporation of health parameter measurement devices. Pivotal signs for neonatal monitoring encompass electrocardiogram, body temperature and respiration. As such, adhesive wired sensors have been used for keeping the physiological signals of neonates in check. Development in wireless communication technologies and sensor technologies has empowered the creation of a new generation of healthcare monitoring systems encompassing wearable electronics and photonics.

Recent Fact.MR report envisages the neonatal monitoring equipment market to record a steady 5.7% CAGR during the forecast period (2018-2028). Over 1,070,000 neonatal monitoring equipment are pegged to be sold worldwide by 2028-end. Prominent players operating in the market such as Medtronic Plc, Natus Medical, Inc., Koninklijke Philips NV, and others, are upgrading their portfolio to make it cost-effective, maintain hospital-to-home point-of-care (PoC) continuum, and incorporate value-added services.

Get Free Sample Report Here:

https://www.factmr.com/connectus/sample?flag=S&rep_id=746

Infants born before 37 weeks of gestation have drastically spiked over the past few years, posing greater risk of early death vis-à-vis those born later in pregnancy, according to National Center for Health Statistics’ data for CDC. Accordingly, the rise in preterm birth has escalated the number of NICU admissions which has fueled the demand for neonatal monitoring equipment.

North America has gracefully embraced specialty of hospice and palliative medicine as physicians getting trained as surged at both clinical and academic level. Sheer goals of palliative care incorporating improvement in the quality of life for patients and reducing suffering have along with proving support for the patient and family throughout the treatment process have received accolades from all corners.

Amongst end-users of neonatal monitoring equipment, ventilators is expected to sustain as a preferred product as it continues to register lion’s share in the market. FDA’s recent approvals of patient-triggered ventilators and neutrally-adjusted ventilator assist (NAVA) with respect to invasive and non-invasive ventilation will fare well for the sale of ventilators.

Neonatal Monitoring Equipment Market: Overview

The report offers a robust analysis on the neonatal monitoring equipment market with qualitative and quantitative analysis. The report presents a lucid picture of the dynamics of the market, expanding to drivers, opportunities, trends and restraints. These factors become paramount and have great influence in the growth of the neonatal monitoring equipment market. Further, the report includes the segmentation of the neonatal monitoring equipment market to provide a holistic view.

The report starts with a comprehensive executive summary followed by market background section. The market background section delves into macro-economic factors and value chain analysis. The report also includes technological advancements and mergers and acquisition which have considerable impact in the growth of the neonatal monitoring equipment market. The report also includes market structure analysis which sheds light on market share analysis of top players along with market presence analysis of players. The report also shows the technology roadmap of the market. The report includes investment feasibility matrix along with Product life cycle analysis. The report also encompasses scenario forecast and Porters’ Five force analysis.

Browse Full Report with ToC Here: 

https://www.factmr.com/report/746/neonatal-monitoring-equipment-market

Segment-wise analysis & insights on neonatal monitoring equipment market has been offered that enables readers to gain accurate and transparent insights. The report has branched the neonatal monitoring equipment market in terms of product type, modality, end-user, and region.

North America continues to stay at the vanguard of the neonatal monitoring equipment market, with an estimated market value share of over one-third through the period of forecast. Rate of premature birth has been steadily rising in North America over the past couple of years, according to the CDC, which in turn has increased the number of NICU admissions, thereby creating demand for neonatal monitoring equipment.

The report on neonatal monitoring equipment market is based on the demand-supply approach. The qualitative factors assessed in the course of estimation incorporate recurrence rate, treatment rates for neonatal monitoring equipment. Further, validation of the information is done through primary sources, incorporating surveys, interviews, in-person interactions, opinion of seasoned analyst along with secondary sources encompassing trade journals, verified paid sources and resourceful databases.

The last section delves into the competitive landscape of the neonatal monitoring equipment market with a competition dashboard, developments, benchmarking and deep dive. The section elucidates overview, product portfolio, sales footprint and strategy of leading players in the market.

Several parameters and data points are gathered and centrally managed during NICU admissions, which comprise physiological parameters, sensor readings, device data, and interventions and observations of caregivers. High data volume generated in NICUs are leveraged for predictive monitoring that involves physiological data analysis for identifying infants at high risk, thereby enabling early detection of ailments.

Neonatal Monitoring Equipment Market: Competitive Landscape

The last section delves into the competitive landscape of the neonatal monitoring equipment market with a competition dashboard, developments, benchmarking and deep dive. The section elucidates overview, product portfolio, sales footprint and strategy of leading players in the market.

Have Any Query?? Ask Our Industry Expert

https://www.factmr.com/connectus/sample?flag=AE&rep_id=746

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

sales@factmr.com

www.factmr.com

 

 

Fetal and Neonatal Heart Monitor Market: Concerted Efforts to Reduce Preterm Births Driving Adoption in Hospitals and Neonatal Clinics

April 19, 2019 by Steve Blade  

Global sales of fetal and neonatal heart monitors are likely to surpass 261,000 units in 2018, with rising adoption in the US driving sales. Cardiotocographs remain the highest selling fetal and neonatal heart monitor devices, with global sales equating a valuation of nearly US$ 400 Mn in 2017. Demand continues to remain concentrated in hospitals and neonatal clinics, with the former accounting for a leading share.

Heart-related congenitala disorders in the course of pregnancy or the requirement for medical interventions owing to complications such as umbilical cord compression or premature delivery. Women experiencing high risk pregnancy factors such as diabetes, high blood pressure, gestational blood pressure and preeclampsia, who need continuous monitoring to ensure baby’s wellbeing may find fetal and neonatal heart monitor beneficial. In addition, rise in preterm birth has further signified the importance of fetal and neonatal heart rate monitor.

Get Free Sample Report Here:

https://www.factmr.com/connectus/sample?flag=S&rep_id=750

The number of neonatal intensive care unit (NICU) admission has escalated in the recent years. The NICU integrates trained health care professionals and sophisticated technology aimed at providing specialized care for the tiniest patients. Accordingly, neonatologist along with other health care professionals and parents develop plan of care for high-risk newborns.

There have been several instances of neonatal complications in offspring of pregnant women with heart disease. Obstetric complications and major adverse cardiac events were linked with higher risk of neonatal adverse clinical events (NACE).

There are some underlying issues in the fetal and neonatal heat monitor landscape such as issues with wrong heart rate tracking which can lead to incorrect reading. In the wake of this serious issue, manufacturers are increasingly focusing on rolling out novel and innovative products in the market. For instance, Philips Avalon came up with smart pulse fetal monitoring technology which applies cross channel verification for assuring correct results.

Opportunities Abound in Fetal and Neonatal Heart Monitors for Metabolic Disorder Induced Risks

Despite intensive efforts taken for interpretation of fetal and neonatal heart rate to prevent hypoxia, challenges prevail regarding complete diagnosis of heart rate pattern changes, particularly caused by metabolic disorders. New research approaches are being introduced for facilitating care of fetal and neonatal hypoxia cost-effectively, as a means to alleviate expensive and complication procedure related to computerized Cardiotocograph (CTG).

Browse Full Report with ToC Here: 

https://www.factmr.com/report/750/fetal-and-neonatal-heart-monitor-market

Fetal and Neonatal Heart Monitor Market: Overview

The report offers a robust analysis on the fetal and neonatal heart monitor market with qualitative and quantitative analysis. The report presents a lucid picture of the dynamics of the market, expanding to drivers, opportunities, trends and restraints. These factors become paramount and have great influence in the growth of the fetal and neonatal heart monitor market. Further, the report includes the segmentation of the fetal and neonatal heart monitor market to provide a holistic view.

The report starts with a comprehensive executive summary followed by market background section. The market background section delves into macro-economic factors and value chain analysis. The report also includes technological advancements and mergers and acquisition which have considerable impact in the growth of the fetal and neonatal heart monitor market. The report also includes market structure analysis which sheds light on market share analysis of top players along with market presence analysis of players. The report also shows the technology roadmap of the market. The report includes investment feasibility matrix along with Product life cycle analysis. The report also encompasses scenario forecast and Porters’ Five force analysis.

The report on fetal and neonatal heart monitor market is based on the demand-supply approach. The qualitative factors assessed in the course of estimation incorporate recurrence rate, treatment rates for fetal and neonatal heart monitor. Further, validation of the information is done through primary sources, incorporating surveys, interviews, in-person interactions, opinion of seasoned analyst along with secondary sources encompassing trade journals, verified paid sources and resourceful databases.

The last section delves into the competitive landscape of the fetal and neonatal heart monitor market with a competition dashboard, developments, benchmarking and deep dive. The section elucidates overview, product portfolio, sales footprint and strategy of leading players in the market.

Fetal and Neonatal Heart Monitor Market: Competitive Landscape

The last section delves into the competitive landscape of the fetal and neonatal heart monitor market with a competition dashboard, developments, benchmarking and deep dive. The section elucidates overview, product portfolio, sales footprint and strategy of leading players in the market.

Have Any Query?? Ask Our Industry Expert

https://www.factmr.com/connectus/sample?flag=AE&rep_id=750

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

sales@factmr.com

www.factmr.com

Dual Chamber Prefilled Syringes Market: Conventional Prefilled Syringes to Be Most Preferred Products

April 19, 2019 by Steve Blade  

  According to Fact.MR’s recently collated research report, a spectacular growth has been envisaged for the global dual chamber prefilled syringes market in the forecast period (2017-2026). Worldwide sales of dual chamber prefilled syringes are poised to bring in approximately US$ 3,300 Mn revenues by 2026-end.

Dual chamber prefilled syringes have evolved to the stage where they are functionally useful for the packaging of lyophilized small volume parental drugs. This development could be attributed to the outgrowth of robust proliferation of biological drugs needing lyophilization.

Over the past decade, several companies have started to focus on approaches such as life-cycle management in order to improve the competitiveness of their existing products. This can be credited to the rising stringency of regulatory parameters along with reduction in the number of novel and guaranteed successful drugs in biopharmaceutical and pharmaceutical pipelines.

For More Details - A sample of this report is available upon request here -

https://www.factmr.com/connectus/sample?flag=S&rep_id=486

Owing to the existence of vast number of parenteral drugs, custom drug delivery devices with prefilled syringes are imperative. As such, companies look to offer exhaustive portfolio of high-quality products and adapt the syringe system to the customer’s individual requirements profile. Accordingly, use of prefilled syringes in parental drugs is enjoying an increase in popularity.

Prefilled syringes have gained popularity owing to enhanced user safety, ease of use and the decline of potential dosage errors. At-home administration, self-administration and the surge of biologics are the primary aspects that trigger the growth of dual chamber prefilled syringes market. On account of low cost and adoption of self-administered drugs, conventional prefilled syringes are expected to be most preferred products in the market. Meanwhile, prefilled has become integral part of auto-injection segment of the drug delivery market, which needs prefilled cartridges.

Dual chamber prefilled syringes have garnered attention of customers as prefilling pays off in saved bulk substance as vials applied for standard injections have to be overfilled. Besides, sealing the containers leverages for ingenious and new packaging methods and exact tracking systems to avert tampering, mix-ups and mistakes that could jeopardize the integrity of a drug between patients and filing line.

The safety and flexibility of the prefills is in line with the growing trend towards home health care. Demographics—ageing population are propelling the trend coupled with the efforts of insurance companies to reduce health-care costs.

Browse Full Report with ToC Here: 

https://www.factmr.com/report/486/dual-chamber-prefilled-syringes-market

Dual Chamber Prefilled Syringes Market: Overview

The report provides a comprehensive assessment on the dual chamber prefilled syringes market with quantitative and qualitative analysis. Further, the report offers a clear picture with respect to dynamics of dual chamber prefilled syringes market, including drivers, trends, opportunities, and restraints. These aspects are indispensable and possess potency to impact the growth of the dual chamber prefilled syringes market. Besides, the report delves into the segregation of the dual chamber prefilled syringes market to provide a robust picture of dual chamber prefilled syringes market.

North America is likely to prevail as the fast-expanding as well as the most lucrative market for dual chamber prefilled syringes, followed by Europe. Asia-Pacific excluding Japan (APEJ) will also account for a major chunk of the market’s revenue share during the forecast period.

The report incorporates exhaustive executive summary followed by market introduction section. The report also presents lucid picture of through market overview and market analysis. The market background section focuses on value chain analysis and macro-economic factors. The report also encompasses mergers and acquisitions along with technological advancements that have significant influence in the development of the dual chamber prefilled syringes market.

Validation of the information in the report is done through primary sources, including in-person interactions, surveys, view of seasoned analyst, interviews and in-person interactions and insights of analyst coupled with secondary sources incorporating trade journals, verified paid sources, resourceful databases and trade journals. Absolute dollar opportunity analysis has also formed basis for the robust analysis of the report.

Dual Chamber Prefilled Syringes Market: Competitive Landscape

The report also includes competitive scenario of the dual chamber prefilled syringes market, including competition intensity mapping with respect to market taxonomy; competition dashboard and company profiles. The section, based on Porters’ Five Force Analysis, also sheds light on financials overview, strategies, product portfolio and recent developments.

Some players in the market are also focusing on making improvements in design of dual chamber prefilled syringes for improving stability and safety of sensitive drugs. Fact.MR’s report has listed key players augmenting the market expansion, which include Bespak Europe Ltd, Catalent, Inc., Credence MedSystems, Inc., Otsuka America Pharmaceutical, Inc., Schott AG, West Pharmaceutical Services, Inc., Ypsomed Holding AG, Gerresheimer AG, Vetter Pharma-Fertigung GmbH & Co. KG, Nipro Corporation, Boehringer Ingelheim GmbH, Amgen Inc., and Pfizer Inc.

Have Any Query?? Ask Our Industry Expert

https://www.factmr.com/connectus/sample?flag=AE&rep_id=486

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

sales@factmr.com

www.factmr.com

North America to enjoy Supremacy over the Global Cell Lines Market Backed by its Technological Advancements

April 19, 2019 by Steve Blade  

According to Fact.MR’s research report on the global cell lines market, the market is anticipated to show a moderate growth rate during the forecasted period of 2017-2022 and expected to reflect a value of more than US$ 140 Mn. Demand for cell lines has been surging at a burgeoning rate, owing to its myriads of applications in the segments such as biochemistry, drug discovery, and molecular biology, among others. There has been a demand for effective treatment for the pervasive chronic diseases, which is met by the vaccines developed using cell lines.

Rapid adoption of regenerative medicines, enhanced healthcare expenditures, and rise in the funding in the biotechnology industry are some of the strong growth drivers of the cell lines market. Widespread detection of cancer has hard pressed the health organizations to develop an effective cure for the disease, which has been addressed by cell lines, attributed to its cost-effectiveness, pure cell population, and ease in use.

Browse Full Report with TOC:

https://www.factmr.com/report/180/cell-lines-market

According to a recently published report on Cell Lines Market by Fact.MR, the global cell lines market is projected to record revenue growth of US$ 140 Mn through 2022. North America is anticipated to reign supreme in the global cell lines market with an estimated CAGR of over 3% through 2022, backed by the technological advancements in this region. Furthermore, the region’s high spending capacity on the research and development cost is expected to fuel the growth of the cell lines market.

The Fact.MR report provides segment-wise analysis and forecast for covering the wide scope of global cell lines market. Product type, end user, application and region are key segments that define the growth of the global market for cell lines. In this segmentation analysis, a detailed country-wise forecast across all key market parameters is also included.

By product, the cancer cell lines segment reflects a higher market revenue share and reflects dominance over other segments in this category. On the other hand, ion channel cell lines are expected to grow at the higher pace comparatively to reflect growth at the CAGR of 3.8% during the period of forecast, 2017 to 2022. The cancer cell lines segment is expected to experience a higher gain in the BPs by the end of 2022 followed by the GPCR cell lines segment which is anticipated to be the second fast growing segment after ion channel cell line segment

Cell Lines Market: Purview of the Report

The primary aim of the market study is to lend a holistic outlook to the stakeholders of the cell lines market with the help of a descriptive executive summary. The market has been analyzed for the period – 2017 – 2022, wherein 2017 is the base year and the forecast has been provided for 2018 to 2022. The market study commences with a brief explanation of the crucial market definitions, along with market valuation and analysis of the year-on-year growth.

The report provides key insights on the demand drivers, opportunities, restraints, threats, and challenges present in the cell lines market. This incisive report also covers in-depth information on the key trends and recent development influencing the growth of the cell lines market. Market has been evaluated in terms of revenue (US$ Mn).

Request Free Sample  Report Here:

https://www.factmr.com/connectus/sample?flag=S&rep_id=180

A comprehensive study on the supply chain, pricing analysis, regulatory approval, cost structure, and sourcing of raw materials has been incorporated in the report. Brief information has been incorporated on the attractiveness of the market obtained by evaluating the market on the basis of product type, application, end user, and region.

Look at the Geographical Segmentation and Competitive Matrix of the Cell Lines Market

The report comprises of a detailed analysis of the market at a regional level. The regions included in the report comprise of North America, Latin America, Europe, Japan, Asia Pacific except Japan (APEJ), Japan, and the Middle East and Asia (MEA). Brief analysis on each of these regions has been included in the report.

Behemoths profiled in the report constitutes of General Electric Company, Abzena Plc., Sigma-Aldrich Corporation, Selexis SA, WuXi AppTec Co., Ltd., Sartorius AG, Corning Incorporated, Lonza Group Ltd., Thermo Fisher Scientific, Inc., and American Type Culture Collection Inc. The report profiles comprehensive information on each of these players, along with their financials, market share, market size, and business strategies.

For More Information Raise Enquiry:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=180

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

sales@factmr.com

www.factmr.com

Urea Formaldehyde Market: Growing Applications in Thriving Wood Industry Generating OpportunitiesĀ 

April 18, 2019 by Steve Blade  

 The report on urea formaldehyde market is a comprehensive amalgam of highly useful and actionable insights. The Fact.MR report provides an extensive assessment on the urea formaldehyde market, which manifests research on noteworthy dynamics, such as lucrative opportunities, key insights, trends, growth drivers, and restraints for the urea formaldehyde market. The report evaluates the size of the urea formaldehyde market in terms of volume (Kilo Tons) and value (US$ Mn).

Urea formaldehyde sales are highly influenced by increasing demand from the building and construction industry. The growing use of formaldehyde as an important chemical to manufacture building materials and several household products has been identified as a key factor likely to fuel urea formaldehyde market growth. The urea formaldehyde market surpassed 14,000 kilo tons sales in 2018 and will record nearly 4% y-o-y growth in 2019, according to a recent Fact.MR report.

Request Free Sample Report Here:

https://www.factmr.com/connectus/sample?flag=S&rep_id=2950

The Fact.MR study estimates healthy gains from the wood industry, owing to the sustainability benefits of urea formaldehyde resins in wood panel and board products, in terms of forest resource conservation and waste reduction. For example, composite wood panels, such as particleboard, are generally composed of recovered wood waste, which is otherwise disposed of in a landfill. Not only does formaldehyde-based chemistry result into greater utilization of wood, but it helps forming robust, highly durable building materials compared to wood, thereby witnessing high demand from particle board manufacturers.

Browse Full report with TOC:

https://www.factmr.com/report/2950/urea-formaldehyde-market

The report provides a through analysis and estimate on urea formaldehyde market on the basis of segmental analysis. The key segments identified in urea formaldehyde market include region, application, and end-use. Fact.MR analysts have analyzed the urea formaldehyde market segments, thereby, providing an explicit comparison between key market data, including the market share, revenue, volume, and Y-o-Y growth.  The report also carries regional performance of urea formaldehyde market, classifying the market into North America, Europe, Japan, Asia-Pacific excluding Japan (APEJ), Middle East & Africa (MEA), and Latin America.  

APEJ Held Over 50% Urea Formaldehyde Sales in 2018

According to Fact.MR study, APEJ held over 50% sales of urea formaldehyde in 2018, and will record a 5.0% Y-o-Y in 2019. The urea formaldehyde market in APEJ continues to remain driven by their bolstering demand in diverse end-use industries, particularly in the construction and building industry. Gains will also be healthy in Europe, on the account of growing adoption of formaldehyde resins by particle board, and medium-density fireboard manufacturing industries in the region.

Some of the key players operating in the global urea formaldehyde market are BASF SE, Advachem, Ashland Inc., Ineos Group, Georgia-Pacific, Acron Group, Hexion Inc., CHIMICA POMPONESCO S.P.A., OJSV “Perechin timber and chemical plant”, PJSC METAFRAX, Achema, Asta Chemicals Sdn. Bhd., etc. 

Have Any Query?? Ask Our Industry Expert:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=2950

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

sales@factmr.com

www.factmr.com

Read Full PR Here:

https://www.factmr.com/media-release/885/urea-formaldehyde-market